Cormorant Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,456,800
| Closed | -$34.5M | – | 61 |
|
|
2023
Q4 | $34.5M | Sell |
2,456,800
-2,047,964
| -45% | -$28.7M | 1.65% | 19 |
|
|
2023
Q3 | $55.6M | Buy |
4,504,764
+1,422,764
| +46% | +$17.6M | 3.25% | 7 |
|
|
2023
Q2 | $27.8M | Hold |
3,082,000
| – | – | 1.56% | 18 |
|
|
2023
Q1 | $10.7M | Buy |
3,082,000
+1,000,000
| +48% | +$3.47M | 0.7% | 36 |
|
|
2022
Q4 | $5.1M | Hold |
2,082,000
| – | – | 0.34% | 56 |
|
|
2022
Q3 | $5.75M | Hold |
2,082,000
| – | – | 0.4% | 50 |
|
|
2022
Q2 | $8.47M | Hold |
2,082,000
| – | – | 0.64% | 42 |
|
|
2022
Q1 | $8.87M | Sell |
2,082,000
-87,871
| -4% | -$374K | 0.68% | 44 |
|
|
2021
Q4 | $20.3M | Sell |
2,169,871
-903,614
| -29% | -$8.46M | 1.21% | 25 |
|
|
2021
Q3 | $84.7M | Hold |
3,073,485
| – | – | 3.44% | 6 |
|
|
2021
Q2 | $86M | Sell |
3,073,485
-122,059
| -4% | -$3.42M | 2.92% | 7 |
|
|
2021
Q1 | $105M | Hold |
3,195,544
| – | – | 2.34% | 8 |
|
|
2020
Q4 | $148M | Buy |
+3,195,544
| New | +$148M | 3.53% | 5 |
|